Literature DB >> 9763927

[Amebiasis--a differential diagnosis from inflammatory bowel disease].

L H Hansen1, C Lund.   

Abstract

Entamoeba histolytica is a very uncommon etiology of travelers diarrhoea, but may be an important differential diagnosis to inflammatory bowel disease. A misdiagnosis of amoebic colitis as inflammatory bowel disease followed by inadvertent treatment with corticosteroids may be fatal. Current techniques for the diagnosis of amoebiasis include stool studies, endoscopic biopsy and serology. Demonstration of haematophagous trophozoites in feces or in tissue biopsy is the definitive method for diagnosis. Unfortunately both methods have many drawbacks. If the specimens are negative, serology can support the diagnosis especially in a non-endemic area where a positive test is highly predictive of current disease.

Entities:  

Mesh:

Year:  1998        PMID: 9763927

Source DB:  PubMed          Journal:  Ugeskr Laeger        ISSN: 0041-5782


  4 in total

1.  Prevalence of amebiasis in inflammatory bowel disease in Turkey.

Authors:  Sebnem Ustun; Hande Dagci; Umit Aksoy; Yuksel Guruz; Galip Ersoz
Journal:  World J Gastroenterol       Date:  2003-08       Impact factor: 5.742

2.  Entamoeba histolytica - tumor necrosis factor: a fatal attraction.

Authors:  Serge Ankri
Journal:  Microb Cell       Date:  2015-07-06

3.  Approach to amoebic colitis: Epidemiological, clinical and diagnostic considerations in a non-endemic context (Barcelona, 2007-2017).

Authors:  Sílvia Roure; Lluís Valerio; Laura Soldevila; Fernando Salvador; Gema Fernández-Rivas; Elena Sulleiro; Míriam Mañosa; Nieves Sopena; José Luis Mate; Bonaventura Clotet
Journal:  PLoS One       Date:  2019-02-21       Impact factor: 3.240

4.  Prevalence of amebiasis in inflammatory bowel disease in University Clinical Hospital Mostar.

Authors:  Emil Babić; Milenko Bevanda; Mladen Mimica; Maja Karin; Mile Volarić; Ante Bogut; Tatjana Barišić; Danijel Pravdić; Nikica Šutalo
Journal:  Springerplus       Date:  2016-09-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.